AstraZeneca UK is recalling one batch of Bricanyl Injection (terbutaline sulfate) 0.5 mg/ml solution for injection or infusion. This is due to out of specification results for a routinely tested known impurity during stability testing. The affected batch is
|Batch Number||Expiry Date||Pack Size||First Distributed|
|F1029-1||August 2021||5 x 1 mL ampoules||November 2019|
Healthcare professionals are asked to quarantine all remaining stock and return it to the supplier using the supplier’s approved process.
For more information or medical information queries please contact: Tel: +44 (0) 0800 783 0033; email: firstname.lastname@example.org
For supply queries, please contact: Tel: +44 (0) 800 783 0033 (option 1); email: email@example.com